Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Investigation of Cathodic Protection, Morphological, Rheological, and Mechanical Properties of Graphene/Iron Oxide Nanoparticle-Embedded Cold Galvanizing Compounds at Reduced Pigment Volume Concentration. | ACS Omega | 2022 | 35755385 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals Altered Expression of Genes Involved in Hypoxia, Inflammation and Immune Regulation in Pdcd10-Depleted Mouse Endothelial Cells. | Genes (Basel) | 2022 | 35741725 | PubTator, text mining | PubMed |
| Autism Spectrum Disorder and Fetal Alcohol Spectrum Disorder: A Literature Review. | Brain Sci | 2022 | 35741677 | PubTator, text mining | PubMed |
| Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2. | Cancers (Basel) | 2022 | 35740522 | PubTator, text mining | PubMed |
| Targeting mitochondrial metabolism for metastatic cancer therapy. | Mol Carcinog | 2022 | 35723497 | PubTator, text mining | PubMed |
| Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature. | Hepatol Commun | 2022 | 35712812 | PubTator, text mining | PubMed |
| Prediction of Differentially Expressed Genes and a Diagnostic Signature of Preeclampsia via Integrated Bioinformatics Analysis. | Dis Markers | 2022 | 35711567 | PubTator, text mining | PubMed |
Retraction notice to "Iron chelator-induced up-regulation of Ndrg1 inhibits proliferation and EMT process by targeting Wnt/β-catenin pathway in colon cancer cells" [Biochem. Biophys. Res. Commun. 506/1 (2018) 114-121]. | Biochem Biophys Res Commun | 2022 | 35710159 | PubTator, text mining | PubMed |
| The power of heteronemin in cancers. | J Biomed Sci | 2022 | 35705962 | PubTator, text mining | PubMed |
| Integrative analysis to explore the biological association between environmental skin diseases and ambient particulate matter. | Sci Rep | 2022 | 35697899 | PubTator, text mining | PubMed |
| Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer. | Int J Cancer | 2022 | 35689436 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers. | Nucleic Acids Res | 2022 | 35687133 | PubTator, text mining | PubMed |
| Changes in the Transcriptome Caused by Mutations in the Ribosomal Protein uS10 Associated with a Predisposition to Colorectal Cancer. | Int J Mol Sci | 2022 | 35682850 | PubTator, text mining | PubMed |
| Hypoxia Selectively Increases a SMAD3 Signaling Axis to Promote Cancer Cell Invasion. | Cancers (Basel) | 2022 | 35681731 | PubTator, text mining | PubMed |
| Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis. | Cancers (Basel) | 2022 | 35681635 | PubTator, text mining | PubMed |
| The Effects of Ovalbumin on Proliferation, Migration, and Stemness Properties of Chemoresistant SW480 Colon Cancer Cells. | Nutr Cancer | 2022 | 35675283 | PubTator, text mining | PubMed |
| Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia. | Future Med Chem | 2022 | 35670251 | PubTator, text mining | PubMed |
| Biological and Clinicopathological Characteristics of OPN in Cervical Cancers. | Front Genet | 2022 | 35669197 | PubTator, text mining | PubMed |
| The evolving landscape of prostate cancer somatic mutations. | Prostate | 2022 | 35657155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=35